Number of SEER-MHOS (1998-2019) Respondents (Age 65+) by First Cancer Site
| First Cancer (#) | Number of linked Patients with One or More survey (Group A) |
More than one survey* (Subset of Group A) |
Survey before Cancer Diagnosis (Group B) |
Survey both before and after Cancer Diagnosis** (Subset of Group B) |
Survey after Cancer Diagnosis (Group C) |
||||
|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | ||
| Prostate (28010) | 52,033 | 25,118 | (48.27) | 16,919 | (32.52) | 3,991 | (7.67) | 39,099 | (75.14) |
| Breast (26000) | 45,891 | 23,154 | (50.45) | 15,817 | (34.47) | 3,434 | (7.48) | 33,499 | (73.00) |
| Colorectal (21041-21052) | 28,006 | 13,432 | (47.96) | 12,818 | (45.77) | 2,034 | (7.26) | 17,218 | (61.48) |
| Lung and bronchus (22030) | 25,111 | 10,604 | (42.23) | 19,864 | (79.10) | 1,513 | (6.03) | 6,753 | (26.89) |
| Ovary (27040) | 2,756 | 1,280 | (46.44) | 1,571 | (57.00) | 160 | (5.81) | 1,345 | (48.80) |
| Uterus (27020, 27030) | 8,357 | 4,125 | (49.36) | 2,765 | (33.09) | 546 | (6.53) | 6,138 | (73.45) |
| Cervix (27010) | 1,177 | 534 | (45.37) | 327 | (27.78) | 40 | (3.40) | 890 | (75.62) |
| Bladder (29010) | 14,073 | 6,808 | (48.38) | 7,153 | (50.83) | 1,216 | (8.64) | 8,136 | (57.81) |
| Melanomas – skin (25010) | 14,300 | 7,429 | (51.95) | 6,378 | (44.60) | 1,195 | (8.36) | 9,088 | (63.55) |
| Head and Neck (20010-20100,22010,22020) | 6,562 | 3,010 | (45.87) | 2,987 | (45.52) | 462 | (7.04) | 4,037 | (61.52) |
| Kidney and Renal pelvis (29020) | 6,440 | 3,036 | (47.14) | 3,276 | (50.87) | 518 | (8.04) | 3,682 | (57.17) |
| Non-Hodgkin's lymphomas - nodal and extranodal (33041,33042) |
8,887 | 4,296 | (48.34) | 5,014 | (56.42) | 695 | (7.82) | 4,568 | (51.40) |
| Stomach (21020) | 3,332 | 1,420 | (42.62) | 2,372 | (71.19) | 199 | (5.97) | 1,159 | (34.78) |
| Pancreas (21100) | 4,841 | 2,043 | (42.20) | 4,431 | (91.53) | 164 | (3.39) | 574 | (11.86) |
* At least one survey must be two years after first survey.
** Number of individuals with a survey before their first cancer diagnosis and also a survey after their first cancer diagnosis.
Note:
- The denominator for the percentages that appear in columns 3 through 6 is the Number of linked patients with one or more survey by cancer site (column 2).
- The groups in columns 4 through 6 are not mutually exclusive, therefore, the percentages do not sum to 100.